Heliox therapy in acute severe asthma

Area of Science:

• Pulmonary Medicine
• Emergency Medicine
• Critical Care

Background:

• Acute severe asthma can lead to respiratory acidosis, a critical condition requiring prompt intervention.
• Helium-oxygen (heliox) mixtures are explored for their potential benefits in improving airflow in obstructive airway diseases.

Purpose of the Study:

• To evaluate the effectiveness of heliox therapy in patients experiencing respiratory acidosis due to acute severe asthma.
• To identify predictors of response to heliox treatment in this patient population.

Main Methods:

• A consecutive case series of 12 asthma patients with acute respiratory acidosis (pH < 7.35, PaCO2 ≥ 45 mm Hg) treated with heliox (60-70% helium/30-40% oxygen).
• Heliox was administered via ventilator (5 patients) or face mask (7 patients).
• Arterial blood gases were measured before and approximately 49 minutes after initiating heliox therapy.

Main Results:

• Heliox therapy significantly decreased PaCO2 (from 57.9 to 47.5 mm Hg, p < 0.005) and increased arterial pH (from 7.23 to 7.32, p < 0.001).
• Two-thirds of patients (8/12) were classified as responders, defined by a significant drop in PaCO2 and rise in pH.
• Responders had shorter symptom duration (17.8 vs 78.0 hours, p < 0.05) and lower preheliox pH (7.20 vs 7.30, p < 0.05).
• All responders presented within 24 hours of symptom onset; non-responders often had prolonged symptoms and some required intubation.

Conclusions:

• Heliox administration can rapidly enhance ventilation in emergency department patients with acute severe asthma and respiratory acidosis.
• A shorter duration of symptoms appears to be a key predictor of a positive response to heliox therapy in this clinical setting.